BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14654910)

  • 1. Safety and efficacy of concurrent interstitial radiation and hyperthermia in the treatment of progressive malignant brain tumors.
    Narayan P; Crocker I; Elder E; Olson JJ
    Oncol Rep; 2004 Jan; 11(1):97-103. PubMed ID: 14654910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
    Strnad V; Geiger M; Lotter M; Sauer R
    Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interstitial hyperthermia of malignant brain tumors using implant heating system (IHS)].
    Kobayashi T; Kida Y; Matsui M; Amemiya Y
    No Shinkei Geka; 1990 Mar; 18(3):247-52. PubMed ID: 2359474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A feasibility study of interstitial hyperthermia plus external beam radiotherapy in glioblastoma multiforme using the Multi ELectrode Current Source (MECS) system.
    Hulshof MC; Raaymakers BW; Lagendijk JJ; Koot RW; Crezee H; Stalpers LJ; González González D
    Int J Hyperthermia; 2004 Aug; 20(5):451-63. PubMed ID: 15277019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
    Benitez PR; Chen PY; Vicini FA; Wallace M; Kestin L; Edmundson G; Gustafson G; Martinez A
    Am J Surg; 2004 Oct; 188(4):355-64. PubMed ID: 15474426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The first experience in interstitial brachytherapy for primary and metastatic tumors of the brain].
    Bentsion DL; Gvozdev PB; Sakovich VP; Fialko NV; Kolotvinov VS; Baiankina SN
    Zh Vopr Neirokhir Im N N Burdenko; 2006; (1):18-21; discussion 21. PubMed ID: 16739930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
    Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE
    Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Volumetric changes following 125I interstitial brachytherapy of gliomas].
    Julow J; Viola A; Major T; Mangel L; Bajzik G; Repa I; Sági S; Valálik I; Emri M; Trón L; Németh G
    Ideggyogy Sz; 2005 Mar; 58(3-4):120-32. PubMed ID: 15887415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
    Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
    Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience.
    Brabham JG; Cardenes HR
    Am J Clin Oncol; 2009 Aug; 32(4):417-22. PubMed ID: 19451799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
    Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
    Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.
    Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
    Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
    Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base.
    Strege RJ; Kovács G; Maune S; Holland D; Niehoff P; Eichmann T; Mehdorn HM
    Strahlenther Onkol; 2005 Feb; 181(2):97-107. PubMed ID: 15702298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.